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Surgical Ablation of Atrial Fibrillation
The classic Maze procedure opened the door of treatment of atrial ﬁbrillation (AF)1,2) and
gave us a suggestion of the mechanism of AF occurrence and maintenance. In the classic
Maze procedure, right and left atrial incisions and cryoablations are constructed to interrupt
the multiple reentrant circuits of AF.2) In addition, these lesions direct the sinus impulse
from the sinoatrial node to the atrioventricular node along a speciﬁed route. Key
components of the Maze procedure include isolation of the pulmonary veins, excision of the
left atrial appendage and interruption of macro-reentrant circuits. Many centers conﬁrmed
results with restration of sinus rhythm in 75% and 90% of patients, low risk of late stroke
and very low operative morbidity and mortality.3,4) Indications for the Maze procedure were
chronic AF in patients requiring other cardiac surgical procedures and lone AF that was
either highly symptomatic or associated with stroke.
Recently, there have been dramatic changes in the surgical ablation of AF. New
technologies that enable rapid creation of lines of conduction block have been embraced
and applied by surgeons to ablate AF in patients having concomitant cardiac surgical
procedures. The development of new surgical approaches to AF has been predicted upon 2
factors: 1) Recognition that the pulmonary veins and left atrium are critical to the initiation
and maintenance of AF5) and 2) development of ablation technologies that use alternate
energy sources to facilitate rapid and safe creation of lines of conduction block under direct
vision. While the Maze procedure was designed to interrupt the multiple macro-reentrant
circuits that characterize AF, new approaches are most precisely anatomically focused.
There is general agreement that development of AF requires a substrate and a trigger, and
that these substrates and triggers are usually located in the pulmonary veins and left atrium.
Haissaguerre demonstrated that paroxysmal AF originates from ectopic beats in the
pulmonary veins in 94% of cases.5) This likely relates to the anatomic transition from
pulmonary vein endothelium to left atrial endothelium; at this junction, two types of tissue
with diﬀerent electrical properties are juxtaposed, and this may potentiate development of
AF. Catheter ablation of pulmonary vein foci has proven eﬀective at ablating paroxysmal
AF, and strategies that isolate all 4 pulmonary veins have further enhanced results of
catheter-based ablation.
As regards persistent and permanent AF, intraoperative left atrial mapping of patients
with persistent AF demonstrated that the left atrium acted as the electrical driving chamber
in most patients.6) In surgical patients with persistent AF and mitral valve disease, a simple
left atrial procedure successfully ablated AF in 78%.7) These data suggest that modiﬁcation
of the left atrial substrate, in combination with pulmonary vein isolation, is likely to be an
eﬀective strategy for elimination of persistent and permanent AF, both in patients with lone
AF and chronic AF with valvular heart disease. In addition, new ablation tools have been
developed to facilitate surgical ablation of AF. These probes and catheters rely on alternate
energy sources to create long, linear lesions that block conduction. Energy sources that have
been used clinically include radiofrequency, laser, ultrasound, microwave, and cryothermy.
Results of left atrial lesion sets suggest that AF is cured in 70% to 80% of patients having
ablation with concomitant heart surgery.8) Most treated patients have had organic heart
disease and have received a mitral valve procedure in addition to AF ablation. Success of
AF ablation is similar regardless of whether right atrial lesion are included. Factors that
inﬂuence procedure success include larger left atrial size, longer duration of AF, and choice
of lesion set in permanent AF.8) After successful ablation, atrial transport function is
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demonstrated in 80% to 100%.8) Further improvement of ablation technology and
diagnostic procedure will eliminate paroxysmal or chronic AF completely.
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